# Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis

> **NCT01199640** · PHASE2 · COMPLETED · sponsor: **Millennium Pharmaceuticals, Inc.** · enrollment: 50 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** MLN1202

## Key facts

- **NCT ID:** NCT01199640
- **Lead sponsor:** Millennium Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-07
- **Final completion:** 2007-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2010-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01199640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01199640, "Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01199640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*